Vutrisiran in Patients with Transthyretin Amyloidosis with CardiomyopathyMarianna Fontana, Mathew S. Maurer, Ali Abbas Yılmaz et al.|New England Journal of Medicine|2024Cited by 356
Clinical Features and Natural History of PRKAG2 Variant Cardiac GlycogenosisÁngela López‐Sainz, Diego Alonso-García, Fernándo Domínguez et al.|Journal of the American College of Cardiology|2020Cited by 104
Mavacamten in Symptomatic Nonobstructive Hypertrophic CardiomyopathyMilind Y. Desai, Steven E. Nissen, Kathy Wolski et al.|New England Journal of Medicine|2025Cited by 51
Short- and medium-term prognosis of Takotsubo syndrome in a Portuguese populationDina Bento, Nuno Marques, Olga Azevedo et al.|Revista Portuguesa de Cardiologia|2019Cited by 23
Predictors of Fabry disease in patients with hypertrophic cardiomyopathy: How to guide the diagnostic strategy?Olga Azevedo, Damião Cunha, Nuno Marques et al.|American Heart Journal|2020Cited by 21